Chronic cerebral hypoperfusion induces venous dysfunction via EPAS1 regulation in mice

Vanessa Kristina Wazny1,2, Aparna Mahadevan1, Nhi Nguyen1

  • 1Neuroscience & Mental Health Program, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

PubMed

Insights

Vascular dementia mechanisms are unclear. This study reveals venous cell changes driven by Epas1 (Endothelial PAS domain-containing protein 1) signaling, offering a therapeutic target for brain blood flow and cognitive health.

Area of Science:

  • Neuroscience
  • Vascular Biology
  • Genetics

Background:

  • Vascular dementia, the second leading cause of dementia, has poorly understood progression mechanisms.
  • Cerebrovascular damage significantly contributes to the development of vascular dementia.

Purpose of the Study:

  • To investigate the cellular and molecular mechanisms underlying cerebrovascular damage in vascular dementia.
  • To identify potential therapeutic targets for restoring cerebrovascular integrity and mitigating neuroinflammation.

Main Methods:

  • Induction of bilateral common carotid artery stenosis in mice to impair cerebral blood flow.
  • Single-cell transcriptomics and advanced imaging of the mouse cortex.
  • In vitro human cell models and in vivo studies with EPAS1 inhibition.
  • Correlation analysis in human subjects linking endothelial cell damage to cognitive function.

Main Results:

  • Venous endothelial cells exhibit maladaptive structural changes and increased Epas1 expression under impaired blood flow.
  • Low-oxygen conditions activate sustained EPAS1 signaling specifically in venous cells.
  • EPAS1 inhibition ameliorates cerebrovascular abnormalities, reduces microglial activation, and improves cerebral perfusion markers.
  • Elevated levels of damaged venous endothelial cells in humans correlate with white matter injury and cognitive decline.

Conclusions:

  • Epas1 signaling in venous cells plays a critical role in the progression of cerebrovascular damage.
  • EPAS1 represents a promising therapeutic target for vascular dementia.
  • Restoring cerebrovascular integrity via EPAS1 modulation may mitigate neuroinflammation and improve cognitive function.